HNO Nachrichten

, Volume 43, Issue 6, pp 31–40 | Cite as

Die nasale Provokationstestung mit Allergenen

Ungefährliche Durchführung, hohe Aussagekraft
  • Dorotheea Cazan
  • Björn Hackenberg
  • Oliver Pfaar
  • Ludger Klimek
Zertifizierte Fortbildung

Zusammenfassung

Der nasale Provoaktionstest ist ein standardisiertes Verfahren zum Nachweis der klinischen Relevanz einer allerigschen Rhinitis mit hoher Spezifität und Sensitivität. Zur Auswertung stehen neben subjektiven semiquantitativen Kriterien auch etablierte objektivierende Messverfahren zur Verfügung.

Literatur

  1. 1.
    Goldschmidt H, Hauswald B, Klimek L, Schlenter W, Tasmann A, Wagenmann M. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J 2002; 11: 29–36Google Scholar
  2. 2.
    Halpern SR, Holman J, Whittaker C. The correlation between skin and respiratory mucous membrane tests with molds in allergic rhinitis. Ann Allergy 1961; 19: 1407–14PubMedGoogle Scholar
  3. 3.
    Blackley C. Experimental researches on the cause and nature of catarrhus aestivus (hay fever of hay asthma). London — Paris — Madrid: Baillière, Tindall & Cox, 1873. Daxson’s of Pall Mall, Nachdruck 1959Google Scholar
  4. 4.
    Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. J Allergy Clin Immunol 2005; 115(3 Suppl 1): S460–82PubMedCrossRefGoogle Scholar
  5. 5.
    Albegger K. [Diagnosis of allergic rhinitis. I. Anamnesis — ENT medical examination — skin tests — intranasal provocation]. HNO 1991; 39: 77–81PubMedGoogle Scholar
  6. 6.
    Bachert C. [Reproducibility of the intranasal provocation test]. Laryngol Rhinol Otol 1987; 66: 157–60CrossRefGoogle Scholar
  7. 7.
    Gosepath J, Amedee RG, Mann WJ. Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. Laryngoscope 2005; 115: 512–6PubMedCrossRefGoogle Scholar
  8. 8.
    Saloga J, Klimek L, Buhl R, Knop J. Allergologie-Handbuch: Grundlagen und klinische Praxis. 2. Aufl. Stuttgart: Schattauer, 2011Google Scholar
  9. 9.
    Heppt W, Bachert C. Praktische Allergologie. 2. Aufl. Stuttgart: Thieme, 2011Google Scholar
  10. 10.
    Chapman MD, Ferreira F, Villalba M, Cromwell O, Bryan D, Becker WM, Fernandez-Rivas M, Durham S, Vieths S, Ree R van. The European Union CREATE project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol 2008; 122: 882–9 e2PubMedCrossRefGoogle Scholar
  11. 11.
    Riechelmann H et al. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J 2002; 11: 29–36Google Scholar
  12. 12.
    Schlenter W. Die nasale Provokationstestung. Allergologie 1990; 13: 42–52Google Scholar
  13. 13.
    Klimek L, Mösges R, Riechelmann H. Diagnostik der allergischen Rhinitis. In: Mösges R, Schlöndorf G (eds). Topische Therapie der allergischen Rhinitis. Zülpich: Biermann, 1993Google Scholar
  14. 14.
    Druce HM, Schumacher MJ. Nasal provocation challenge. The Committee on Upper Airway Allergy. J Allergy Clin Immunol 1990; 86: 261–4PubMedCrossRefGoogle Scholar
  15. 15.
    Vogt K, Jalowayski A, Althaus W, Cao C, Han D, Hasse W, Hoffrichter H, Mosges R, Pallanch J, Shah-Hosseini K, Peksis K, Wernecke KD, Zhang L, Zaporoshenko P. 4-Phase-Rhinomanometry (4PR) — basics and practice 2010. Rhinol Suppl 2010; 21: 1–50PubMedGoogle Scholar
  16. 16.
    Lenders H, Gall H. Die nasale Provokationstestung. Ein Vergleich zwischen anteriorer Rhinomanometrie und akustischer Rhinomanometrie. Allergologie 1992; 7: 233–9Google Scholar
  17. 17.
    Cheung EJ, Citardi MJ, Fakhri S, Cain J, Batra PS, Luong A. Comparison of optical rhinometry to acoustic rhinometry using nasal provocation testing with Dermatophagoides farinae. Otolaryngol Head Neck Surg 2010; 143: 290–3PubMedCrossRefGoogle Scholar
  18. 18.
    Bachert C. [Clinical aspects of environmental illnesses of the nose and paranasal sinuses — science and clinical practice]. Eur Arch Otorhinolaryngol Suppl 1996; 1: 73–153PubMedGoogle Scholar
  19. 19.
    Bacon JR, McLean JA, Mathews KP, Banas JM. Priming of the nasal mucosa by ragweed extract or by an irritant (ammonia). J Allergy Clin Immunol 1981; 67: 111–6PubMedCrossRefGoogle Scholar
  20. 20.
    Connell JT. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. J Allergy 1968; 41: 123–39PubMedCrossRefGoogle Scholar
  21. 21.
    Connell JT. Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy 1969; 43: 33–44PubMedCrossRefGoogle Scholar
  22. 22.
    Majchel A, Proud D, Freidhoff L, Creticos PS, Norman PS, Naclerio RM. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol 1992; 90: 85–91PubMedCrossRefGoogle Scholar
  23. 23.
    Reed CE, Bubak M, Dunnette S, Blomgren J, Pfenning M, Wentz-Murtha P, Wallen N, Keating M, Gleich GJ. Ragweed-specific IgA in nasal lavage fluid of ragweed-sensitive allergic rhinitis patients: increase during the pollen season. Int Arch Allergy Appl Immunol 1991; 94: 275–7PubMedCrossRefGoogle Scholar
  24. 24.
    Skoner DP, Lee L, Doyle WJ, Boehm S, Fireman P. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann Allergy 1990; 65: 206–10PubMedGoogle Scholar
  25. 25.
    Svensson C, Andersson M, Persson CG, Venge P, Alkner U, Pipkorn U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990; 85: 828–33PubMedCrossRefGoogle Scholar
  26. 26.
    Commitee for medicinal products for human use. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. CHMP/EWP/18504/2006, 2008Google Scholar
  27. 27.
    Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355: 1445–55PubMedCrossRefGoogle Scholar
  28. 28.
    Purohit A, Niederberger V, Kronqvist M, Horak F, Gronneberg R, Suck R, Weber B, Fiebig H, Hage M van, Pauli G, Valenta R, Cromwell O. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy 2008; 38: 1514–25PubMedCrossRefGoogle Scholar
  29. 29.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalayci O. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Pediatr Allergy Immunol 2006; 17: 396–407PubMedCrossRefGoogle Scholar
  30. 30.
    Tahamiler R, Saritzali G, Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope 2007; 117: 965–9PubMedCrossRefGoogle Scholar
  31. 31.
    Pfaar O, Barth C, Jaschke C, Hormann K, Klimek L. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study. Int Arch Allergy Immunol 2011; 154: 336–44PubMedCrossRefGoogle Scholar
  32. 32.
    Richelmann H, Hauswald B. Nasaler Provokationstest. Praktische Allergologie 2010: 198–205Google Scholar
  33. 33.
    Subiza J, Feliu JA, Subiza JL, Uhlig E, Fernandez-Caldas E. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment. Clin Exp Allergy 2008; 38: 987–94PubMedCrossRefGoogle Scholar
  34. 34.
    Senti G, Graf N, Haug S, Ruedi N, Moos S von, Sonderegger T, Johansen P, Kundig TM. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 124: 997–1002PubMedCrossRefGoogle Scholar
  35. 35.
    Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wohrl S, Dahlen B, Szczeklik A. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62: 1111–8PubMedCrossRefGoogle Scholar
  36. 36.
    Alonso-Llamazares A, Martinez-Cocera C, Dominguez-Ortega J, Robledo-Echarren T, Cimarra-Alvarez M, Mesa del Castillo M. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy 2002; 57: 632–5PubMedCrossRefGoogle Scholar
  37. 37.
    Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998; 101: 581–6PubMedCrossRefGoogle Scholar
  38. 38.
    Fokkens WJ, Vinke JG, KleinJan A. Local IgE production in the nasal mucosa: a review. Am J Rhinol, 2000; 14(5): 299–303PubMedCrossRefGoogle Scholar
  39. 39.
    Rondon C, Fernandez J, Canto G, Blanca M. Local allergic rhinitis: concept, clinical manifestations, and diagnostic approach. J Investig Allergol Clin Immunol 2010; 20: 364–71; quiz 2 p following 371PubMedGoogle Scholar
  40. 40.
    Rondon C, Romero J, Lopez S, Antunez C, Martin-Casanez E, Torres MJ, Mayorga C, Blanca RM. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol, 2007; 119: 899–905PubMedCrossRefGoogle Scholar
  41. 41.
    Chandra RK, Patadia MO, Raviv J. Diagnosis of nasal airway obstruction. Otolaryngol Clin North Am 2009; 42: 207–25PubMedCrossRefGoogle Scholar

Copyright information

© Urban & Vogel 2013

Authors and Affiliations

  • Dorotheea Cazan
    • 1
  • Björn Hackenberg
    • 1
  • Oliver Pfaar
    • 1
  • Ludger Klimek
    • 2
  1. 1.
  2. 2.Zentrum für Rhinologie und Allergologie WiesbadenWiesbadenDeutschland

Personalised recommendations